Clinical trial
Evaluation of the Treatment of Trapeziometacarpal Osteoarthritis (TMC OA) With a Treated, Devitalized and Sterile Amniotic Membrane of Umbilical Cord Placed in Joint Interposition
NCT07435571 is registered in ClinicalTrials.gov with TBF Genie Tissulaire as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Treatment of Trapeziometacarpal Osteoarthritis (TMC OA) With a Treated, Devitalized and Sterile Amniotic Membrane of Umbilical Cord Placed in Joint Interposition
- Lead sponsor
- TBF Genie Tissulaire
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- November 30, 2026
- Completion date
- March 31, 2028
- Enrollment
- 22 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
trapeziometacarpal osteoarthritis